- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06288568
Night Shift Work and Biomarkers of Obesity Risk in Hospital and Industry Workers (Shift2Health)
Development and Evaluation of Nutritional Strategies to Reduce and Prevent Obesity in Shiftworkers
Shift work is a well-known risk factor for the development of overweight and obesity, which may lead to downstream effects such as increased risk of cardiometabolic diseases and cancer. However, the biological and behavioral mechanisms underlying the obesogenicity of night shift work are not well understood. Population-based mechanistic studies in real life shift workers are needed to address how night shift work impacts metabolic health.
The investigators aim to characterize the behavioural, environmental, and biological mechanisms and pathways for the association of night shift work and obesity across Europe.
The investigators will conduct a cross sectional study in 5 European countries (Austria, Denmark, Germany, Netherlands and Poland) and recruit 1000 rotating night shift workers and day workers (200/country) from the health sector and different industries. Night and day workers will be age-frequency (3 age groups), gender and (where possible) working tasks matched. Participants will complete online questionnaires and report their diet habits in a mobile app. Body composition, dietary behavior and sensory preferences will be tested. Biologic specimens (blood, urine, saliva, hair and feces) will be collected at the workplace on a day where participants are working on a day shift (or a day off). In a subsample (Austria and Netherlands) shift workers will provide biological samples (spot blood, urine and saliva) both on a day shift and on a night shift. Biomarkers including hormones, cellular immunity and inflammation, parameters linked to gut health and metabolism of fat and sugar, appetite, oxidative stress, metabolomics and microbiota will be measured. The investigators hypothesize that compared to day workers, night shift workers will experience disrupted levels of pre-obesity markers. Higher circadian disruption, sleep disruption and mistimed eating patterns workers will be associated with more disrupted biomarker profiles. Among rotating shift workers, night shift will be associated with acute disrupted melatonin production, metabolomic profiles and composition of oral microbiota compared to a day shift.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Vienna
-
Vienna, Vienna, Austria, 1090
- Recruiting
- Medical University of Vienna
-
Contact:
- Kyriaki Papantoniou, MD PhD
- Phone Number: 0043(0)4016034706
- Email: kyriaki.papantoniou@meduniwien.ac.at
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria shift worker
- Health care sector or industrial shift worker
- Employed or self-employed
- 21 years or older
- ≥ 24 h/ week
- Shift work duration > 3 years and currently doing night shifts
- 4 or more rotating night shifts/month (night shift defined as a work schedule that involves working at least 3 hours between 00:00 and 5:00), at least 2 consecutive nights/month
Inclusion criteria controls
- Health care sector or industrial work
- Employed or self-employed
- 21 years or older
- ≥ 24 h/ week
- No night shift or rotating shift work in the last 5 years
- No history of night shift or rotating shift work for more than 5 years
Exclusion Criteria shift worker and controls:
- Pregnancy
- Lactation period
- BMI of 40 kg/m2 or above
- Present treatment of a disease e.g. cancer radio- or chemotherapy
- Chronic diseases if in an ongoing therapy but not after a remission (renal failure, active hepatitis, cirrhosis, myocardial infarction, chronic obstructive pulmonary disease and cancer)
- Immunodeficiency syndrome, any auto-immune or auto-inflammatory diseases (e.g. type-1 diabetes, multiple sclerosis, lupus, rheumatoid arthritis) and acute episodes of atopic diseases (atopic dermatitis, asthma, type 1 allergies such as hay fever)
- Bariatric surgery
- Antibiotics in the last month
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Nightshift workers
Nightshift worker in the health care and industrial sector.
Night shift is defined as a work schedule that involves working at least 3 hours between 00:00 and 5:00, at least 2 consecutive nights/month.
|
No intervention
|
|
Dayshift workers
Dayshift worker in the health care and industrial sector.
No night shifts.
|
No intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
high-sensitive C-Reactive Protein (hs-CRP)
Time Frame: Baseline
|
Compare hs-CRP levels between night shift workers and day shift workers
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The investigators will consider metabolomics analysis of plasma samples and dry blood spots (DBS)
Time Frame: Baseline
|
Compare the levels of various metabolites between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider microbiome analysis of feces samples and tongue swabs
Time Frame: Baseline
|
Compare the levels of various microbiota composition between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of hormones in plasma
Time Frame: Baseline
|
Compare melatonin levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of hormones in plasma
Time Frame: Baseline
|
Compare cortisol levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of parameters linked to gut health in serum and in feces
Time Frame: Baseline
|
Compare Short-chain fatty acids (SCFA) levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of parameters linked to gut health in serum and in feces
Time Frame: Baseline
|
Compare Fatty acid-binding protein (FABP) levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of parameters linked to gut health in serum and in feces
Time Frame: Baseline
|
Compare lipopolysaccharide(LPS)-binding protein levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of parameters linked to gut health in serum and in feces
Time Frame: Baseline
|
Compare zonulin-1 levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider parameters of cellular immunity and inflammation in plasma
Time Frame: Baseline
|
Compare growth factors levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider parameters of cellular immunity and inflammation in plasma
Time Frame: Baseline
|
Compare cytokines levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider parameters of cellular immunity and inflammation in plasma
Time Frame: Baseline
|
Compare chemokines levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider parameters of metabolism of fat and sugar in plasma
Time Frame: Baseline
|
Compare total cholesterol levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider parameters of metabolism of fat and sugar in plasma
Time Frame: Baseline
|
Compare LDL-C levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider parameters of metabolism of fat and sugar in plasma
Time Frame: Baseline
|
Compare HDL-C levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider parameters of metabolism of fat and sugar in plasma
Time Frame: Baseline
|
Compare triglycerides levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider parameters of metabolism of fat and sugar in plasma
Time Frame: Baseline
|
Compare glucose levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of appetite markers in plasma
Time Frame: Baseline
|
Compare leptin levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of appetite markers in plasma
Time Frame: Baseline
|
Compare ghrelin levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of oxidative stress in whole blood, serum, plasma and urine
Time Frame: Baseline
|
Compare DNA damage levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of oxidative stress in whole blood, serum, plasma and urine
Time Frame: Baseline
|
Compare Malondialdehyde (MDA) levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of oxidative stress in whole blood, serum, plasma and urine
Time Frame: Baseline
|
Compare 8-oxo-Guo/Gua levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of oxidative stress in whole blood, serum, plasma and urine
Time Frame: Baseline
|
Compare protein carbonyls levels between night shift workers and day shift workers
|
Baseline
|
|
The investigators will consider levels of oxidative stress in whole blood, serum, plasma and urine
Time Frame: Baseline
|
Compare unconjugated bilirubin levels between night shift workers and day shift workers
|
Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Shift2Health
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown